tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

IONS Stock Latest News

Ionis announces NDA for zilganersen accepted by U.S. FDA for Priority Review
The FlyIonis announces NDA for zilganersen accepted by U.S. FDA for Priority Review
11h ago
IONS
Cathie Wood Invests Over $10M in CRISPR and PAYP Stocks, Trims Stakes in TER and IONS
PremiumMarket News
Cathie Wood Invests Over $10M in CRISPR and PAYP Stocks, Trims Stakes in TER and IONS
10d ago
TEM
TXG
Ionis Pharmaceuticals Announces Board Retirements and New Appointment
PremiumCompany Announcements
Ionis Pharmaceuticals Announces Board Retirements and New Appointment
14d ago
8K
IONS
Ionis Pharmaceuticals price target raised to $100 from $87 at Piper Sandler
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $100 from $87 at Piper Sandler
24d ago
IONS
Ionis Pharmaceuticals announces olezarsen sNDA accepted for FDA priority review
PremiumThe Fly
Ionis Pharmaceuticals announces olezarsen sNDA accepted for FDA priority review
25d ago
IONS
Ionis Pharmaceuticals price target raised to $77 from $73 at Stifel
PremiumThe FlyIonis Pharmaceuticals price target raised to $77 from $73 at Stifel
25d ago
IONS
Ionis Pharmaceuticals Earnings Call Highlights Surging Momentum
Premium
Company Announcements
Ionis Pharmaceuticals Earnings Call Highlights Surging Momentum
26d ago
IONS
Ionis Pharmaceuticals: Accelerating Commercial Momentum, Conservative Guidance, and Late-Stage Pipeline Catalysts Underpin Buy Rating
Premium
Ratings
Ionis Pharmaceuticals: Accelerating Commercial Momentum, Conservative Guidance, and Late-Stage Pipeline Catalysts Underpin Buy Rating
26d ago
IONS
Ionis Pharmaceuticals: Strong 4Q25 Beat and Catalyst-Rich 2026 Underpin Raised Buy Rating and $103 Target
PremiumRatings
Ionis Pharmaceuticals: Strong 4Q25 Beat and Catalyst-Rich 2026 Underpin Raised Buy Rating and $103 Target
26d ago
IONS
Ionis Pharmaceuticals price target raised to $103 from $90 at Needham
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $103 from $90 at Needham
26d ago
IONS
Ionis Pharmaceuticals: Buy Rating Driven by Strong Q4 Beat, Growing Commercial Portfolio, and Pipeline Upside Catalysts
PremiumRatings
Ionis Pharmaceuticals: Buy Rating Driven by Strong Q4 Beat, Growing Commercial Portfolio, and Pipeline Upside Catalysts
26d ago
IONS
Ionis Pharmaceuticals sees FY26 revenue $800M-$825M, consensus $914.39M
PremiumThe Fly
Ionis Pharmaceuticals sees FY26 revenue $800M-$825M, consensus $914.39M
26d ago
IONS
Ionis Pharmaceuticals reports Q4 EPS ($1.41), consensus ($1.22)
PremiumThe FlyIonis Pharmaceuticals reports Q4 EPS ($1.41), consensus ($1.22)
26d ago
IONS
IONS Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
IONS Earnings this Week: How Will it Perform?
29d ago
IONS
Ionis Ends Early-Stage Hero Study in Down Syndrome Alzheimer’s Risk: What Investors Should Know
Premium
Company Announcements
Ionis Ends Early-Stage Hero Study in Down Syndrome Alzheimer’s Risk: What Investors Should Know
1M ago
IONS
Ionis Pharmaceuticals price target raised to $87 from $77 at Piper Sandler
PremiumThe Fly
Ionis Pharmaceuticals price target raised to $87 from $77 at Piper Sandler
2M ago
IONS
Ionis Pharmaceuticals assumed with an Overweight at Barclays
PremiumThe Fly
Ionis Pharmaceuticals assumed with an Overweight at Barclays
2M ago
IONS
Ionis Pharmaceuticals announces European Commission approval for Dawnzera
PremiumThe Fly
Ionis Pharmaceuticals announces European Commission approval for Dawnzera
2M ago
IONS
Cathie Wood Doubles Down on High-Potential Biotech Plays
PremiumMarket News
Cathie Wood Doubles Down on High-Potential Biotech Plays
2M ago
TER
TXG
RBLX, META, GH, IONS: Cathie Wood Loads Up on Roblox, Trims Meta and Biotech Stocks
PremiumMarket NewsRBLX, META, GH, IONS: Cathie Wood Loads Up on Roblox, Trims Meta and Biotech Stocks
3M ago
GH
KDK
Ionis Pharmaceuticals: Underappreciated Bepirovirsen and Multiple Late-Stage Catalysts Support Buy Rating
Premium
Ratings
Ionis Pharmaceuticals: Underappreciated Bepirovirsen and Multiple Late-Stage Catalysts Support Buy Rating
3M ago
IONS
Ionis Advances Bepirovirsen After Positive Phase 3 Results
Premium
Company Announcements
Ionis Advances Bepirovirsen After Positive Phase 3 Results
3M ago
8K
IONS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >